Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Continuous manufacturing involves a pharmaceutical product being produced nonstop in one continuous manufacturing process. The entire process takes place in one facility, start to finish, without hold times.
This report aims to provide a comprehensive study of the global market for Continuous Manufacturing in Pharmaceutical. Report Highlights:
(1) Global Continuous Manufacturing in Pharmaceutical market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Continuous Manufacturing in Pharmaceutical market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Continuous Manufacturing in Pharmaceutical market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Continuous Manufacturing in Pharmaceutical segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Continuous Manufacturing in Pharmaceutical segment by type and by application and regional segment by type and by application.
(6) Continuous Manufacturing in Pharmaceutical industry supply chain, upstream, midstream and downstream analysis.
According to latest study, the global market for Continuous Manufacturing in Pharmaceutical should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Continuous Manufacturing in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Continuous Manufacturing in Pharmaceutical market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Powder segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, In-house has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Continuous Manufacturing in Pharmaceutical include Siemens, Syntegon, Corning, GEA, SK pharmteco, Korsch, Chemtrix, L.B. Bohle and Pharmira, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Powder
Tablet
Capsule
Injection
Others
Market segment by application, can be divided into
In-house
CMO
CDMO
Market segment by players, this report covers
Siemens
Syntegon
Corning
GEA
SK pharmteco
Korsch
Chemtrix
L.B. Bohle
Pharmira
SL Controls
CONTINUUS Pharmaceuticals
Hovione
IMA Group
Dec Group
1 Market Overview
1.1 Product Overview and Scope of Continuous Manufacturing in Pharmaceutical
1.2 Global Continuous Manufacturing in Pharmaceutical Market Size and Forecast
1.3 China Continuous Manufacturing in Pharmaceutical Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Continuous Manufacturing in Pharmaceutical Share in Global Market, 2018-2029
1.4.2 Continuous Manufacturing in Pharmaceutical Market Size: China VS Global, 2018-2029
1.5 Continuous Manufacturing in Pharmaceutical Market Dynamics
1.5.1 Continuous Manufacturing in Pharmaceutical Market Drivers
1.5.2 Continuous Manufacturing in Pharmaceutical Market Restraints
1.5.3 Continuous Manufacturing in Pharmaceutical Industry Trends
1.5.4 Continuous Manufacturing in Pharmaceutical Industry Policy
2 Global Competitive Situation by Company
2.1 Global Continuous Manufacturing in Pharmaceutical Revenue by Company (2018-2023)
2.2 Global Continuous Manufacturing in Pharmaceutical Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Continuous Manufacturing in Pharmaceutical Concentration Ratio
2.4 Global Continuous Manufacturing in Pharmaceutical Mergers & Acquisitions, Expansion Plans
2.5 Global Continuous Manufacturing in Pharmaceutical Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Continuous Manufacturing in Pharmaceutical Revenue by Company (2018-2023)
3.2 China Continuous Manufacturing in Pharmaceutical Continuous Manufacturing in Pharmaceutical Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Continuous Manufacturing in Pharmaceutical, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Continuous Manufacturing in Pharmaceutical Industry Chain
4.2 Continuous Manufacturing in Pharmaceutical Upstream Analysis
4.3 Continuous Manufacturing in Pharmaceutical Midstream Analysis
4.4 Continuous Manufacturing in Pharmaceutical Downstream Analysis
5 Sights by Type
5.1 Continuous Manufacturing in Pharmaceutical Classification
5.1.1 Powder
5.1.2 Tablet
5.1.3 Capsule
5.1.4 Injection
5.1.5 Others
5.2 By Type, Global Continuous Manufacturing in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029
6 Sights by Application
6.1 Continuous Manufacturing in Pharmaceutical Segment by Application
6.1.1 In-house
6.1.2 CMO
6.1.3 CDMO
6.2 By Application, Global Continuous Manufacturing in Pharmaceutical Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Continuous Manufacturing in Pharmaceutical Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
7.3 North America
7.3.1 North America Continuous Manufacturing in Pharmaceutical Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Continuous Manufacturing in Pharmaceutical Market Size Market Share
7.4 Europe
7.4.1 Europe Continuous Manufacturing in Pharmaceutical Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Continuous Manufacturing in Pharmaceutical Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Continuous Manufacturing in Pharmaceutical Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Continuous Manufacturing in Pharmaceutical Market Size Market Share
7.6 South America
7.6.1 South America Continuous Manufacturing in Pharmaceutical Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Continuous Manufacturing in Pharmaceutical Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Continuous Manufacturing in Pharmaceutical Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.3.2 By Company, U.S. Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.4.2 By Company, Europe Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.5.2 By Company, China Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.5.3 By Type, China Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.6.2 By Company, Japan Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.7.2 By Company, South Korea Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.9.2 By Company, India Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.9.3 By Type, India Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Continuous Manufacturing in Pharmaceutical Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Siemens
9.1.1 Siemens Company Information, Head Office, Market Area and Industry Position
9.1.2 Siemens Company Profile and Main Business
9.1.3 Siemens Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.1.4 Siemens Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.1.5 Siemens Recent Developments
9.2 Syntegon
9.2.1 Syntegon Company Information, Head Office, Market Area and Industry Position
9.2.2 Syntegon Company Profile and Main Business
9.2.3 Syntegon Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.2.4 Syntegon Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.2.5 Syntegon Recent Developments
9.3 Corning
9.3.1 Corning Company Information, Head Office, Market Area and Industry Position
9.3.2 Corning Company Profile and Main Business
9.3.3 Corning Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.3.4 Corning Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.3.5 Corning Recent Developments
9.4 GEA
9.4.1 GEA Company Information, Head Office, Market Area and Industry Position
9.4.2 GEA Company Profile and Main Business
9.4.3 GEA Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.4.4 GEA Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.4.5 GEA Recent Developments
9.5 SK pharmteco
9.5.1 SK pharmteco Company Information, Head Office, Market Area and Industry Position
9.5.2 SK pharmteco Company Profile and Main Business
9.5.3 SK pharmteco Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.5.4 SK pharmteco Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.5.5 SK pharmteco Recent Developments
9.6 Korsch
9.6.1 Korsch Company Information, Head Office, Market Area and Industry Position
9.6.2 Korsch Company Profile and Main Business
9.6.3 Korsch Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.6.4 Korsch Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.6.5 Korsch Recent Developments
9.7 Chemtrix
9.7.1 Chemtrix Company Information, Head Office, Market Area and Industry Position
9.7.2 Chemtrix Company Profile and Main Business
9.7.3 Chemtrix Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.7.4 Chemtrix Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.7.5 Chemtrix Recent Developments
9.8 L.B. Bohle
9.8.1 L.B. Bohle Company Information, Head Office, Market Area and Industry Position
9.8.2 L.B. Bohle Company Profile and Main Business
9.8.3 L.B. Bohle Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.8.4 L.B. Bohle Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.8.5 L.B. Bohle Recent Developments
9.9 Pharmira
9.9.1 Pharmira Company Information, Head Office, Market Area and Industry Position
9.9.2 Pharmira Company Profile and Main Business
9.9.3 Pharmira Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.9.4 Pharmira Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.9.5 Pharmira Recent Developments
9.10 SL Controls
9.10.1 SL Controls Company Information, Head Office, Market Area and Industry Position
9.10.2 SL Controls Company Profile and Main Business
9.10.3 SL Controls Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.10.4 SL Controls Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.10.5 SL Controls Recent Developments
9.11 CONTINUUS Pharmaceuticals
9.11.1 CONTINUUS Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.11.2 CONTINUUS Pharmaceuticals Company Profile and Main Business
9.11.3 CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.11.4 CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.11.5 CONTINUUS Pharmaceuticals Recent Developments
9.12 Hovione
9.12.1 Hovione Company Information, Head Office, Market Area and Industry Position
9.12.2 Hovione Company Profile and Main Business
9.12.3 Hovione Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.12.4 Hovione Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.12.5 Hovione Recent Developments
9.13 IMA Group
9.13.1 IMA Group Company Information, Head Office, Market Area and Industry Position
9.13.2 IMA Group Company Profile and Main Business
9.13.3 IMA Group Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.13.4 IMA Group Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.13.5 IMA Group Recent Developments
9.14 Dec Group
9.14.1 Dec Group Company Information, Head Office, Market Area and Industry Position
9.14.2 Dec Group Company Profile and Main Business
9.14.3 Dec Group Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
9.14.4 Dec Group Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
9.14.5 Dec Group Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Continuous Manufacturing in Pharmaceutical Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Continuous Manufacturing in Pharmaceutical Market Restraints
Table 3. Continuous Manufacturing in Pharmaceutical Market Trends
Table 4. Continuous Manufacturing in Pharmaceutical Industry Policy
Table 5. Global Continuous Manufacturing in Pharmaceutical Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Continuous Manufacturing in Pharmaceutical Revenue Market Share by Company (2018-2023)
Table 7. Global Continuous Manufacturing in Pharmaceutical Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Continuous Manufacturing in Pharmaceutical Mergers & Acquisitions, Expansion Plans
Table 9. Global Continuous Manufacturing in Pharmaceutical Manufacturers Product Type
Table 10. China Continuous Manufacturing in Pharmaceutical Revenue by Company (2018-2023) & (US$ million)
Table 11. China Continuous Manufacturing in Pharmaceutical Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Continuous Manufacturing in Pharmaceutical Upstream (Raw Materials)
Table 13. Global Continuous Manufacturing in Pharmaceutical Typical Customers
Table 14. Continuous Manufacturing in Pharmaceutical Typical Distributors
Table 15. By Type, Global Continuous Manufacturing in Pharmaceutical Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Continuous Manufacturing in Pharmaceutical Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Continuous Manufacturing in Pharmaceutical Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Continuous Manufacturing in Pharmaceutical Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2029
Table 22. Siemens Company Information, Head Office, Market Area and Industry Position
Table 23. Siemens Company Profile and Main Business
Table 24. Siemens Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 25. Siemens Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 26. Siemens Recent Developments
Table 27. Syntegon Company Information, Head Office, Market Area and Industry Position
Table 28. Syntegon Company Profile and Main Business
Table 29. Syntegon Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 30. Syntegon Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 31. Syntegon Recent Developments
Table 32. Corning Company Information, Head Office, Market Area and Industry Position
Table 33. Corning Company Profile and Main Business
Table 34. Corning Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 35. Corning Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 36. Corning Recent Developments
Table 37. GEA Company Information, Head Office, Market Area and Industry Position
Table 38. GEA Company Profile and Main Business
Table 39. GEA Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 40. GEA Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 41. GEA Recent Developments
Table 42. SK pharmteco Company Information, Head Office, Market Area and Industry Position
Table 43. SK pharmteco Company Profile and Main Business
Table 44. SK pharmteco Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 45. SK pharmteco Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 46. SK pharmteco Recent Developments
Table 47. Korsch Company Information, Head Office, Market Area and Industry Position
Table 48. Korsch Company Profile and Main Business
Table 49. Korsch Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 50. Korsch Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 51. Korsch Recent Developments
Table 52. Chemtrix Company Information, Head Office, Market Area and Industry Position
Table 53. Chemtrix Company Profile and Main Business
Table 54. Chemtrix Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 55. Chemtrix Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 56. Chemtrix Recent Developments
Table 57. L.B. Bohle Company Information, Head Office, Market Area and Industry Position
Table 58. L.B. Bohle Company Profile and Main Business
Table 59. L.B. Bohle Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 60. L.B. Bohle Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 61. L.B. Bohle Recent Developments
Table 62. Pharmira Company Information, Head Office, Market Area and Industry Position
Table 63. Pharmira Company Profile and Main Business
Table 64. Pharmira Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 65. Pharmira Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 66. Pharmira Recent Developments
Table 67. SL Controls Company Information, Head Office, Market Area and Industry Position
Table 68. SL Controls Company Profile and Main Business
Table 69. SL Controls Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 70. SL Controls Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 71. SL Controls Recent Developments
Table 72. CONTINUUS Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 73. CONTINUUS Pharmaceuticals Company Profile and Main Business
Table 74. CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 75. CONTINUUS Pharmaceuticals Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 76. CONTINUUS Pharmaceuticals Recent Developments
Table 77. Hovione Company Information, Head Office, Market Area and Industry Position
Table 78. Hovione Company Profile and Main Business
Table 79. Hovione Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 80. Hovione Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 81. Hovione Recent Developments
Table 82. IMA Group Company Information, Head Office, Market Area and Industry Position
Table 83. IMA Group Company Profile and Main Business
Table 84. IMA Group Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 85. IMA Group Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 86. IMA Group Recent Developments
Table 87. Dec Group Company Information, Head Office, Market Area and Industry Position
Table 88. Dec Group Company Profile and Main Business
Table 89. Dec Group Continuous Manufacturing in Pharmaceutical Models, Specifications and Application
Table 90. Dec Group Continuous Manufacturing in Pharmaceutical Revenue and Gross Margin, 2018-2023
Table 91. Dec Group Recent Developments
List of Figure
Figure 1. Continuous Manufacturing in Pharmaceutical Picture
Figure 2. Global Continuous Manufacturing in Pharmaceutical Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Continuous Manufacturing in Pharmaceutical Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Continuous Manufacturing in Pharmaceutical Market Share of Global
Figure 5. Global Continuous Manufacturing in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Continuous Manufacturing in Pharmaceutical Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Continuous Manufacturing in Pharmaceutical Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Continuous Manufacturing in Pharmaceutical Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Continuous Manufacturing in Pharmaceutical Industry Chain
Figure 10. Powder
Figure 11. Tablet
Figure 12. Capsule
Figure 13. Injection
Figure 14. Others
Figure 15. By Type, Global Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, US$ Million
Figure 16. By Type, Global Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2029
Figure 17. In-house
Figure 18. CMO
Figure 19. CDMO
Figure 20. By Application, Global Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, US$ Million
Figure 21. By Application, Global Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2029
Figure 22. By Region, Global Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2029
Figure 23. North America Continuous Manufacturing in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
Figure 25. Europe Continuous Manufacturing in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
Figure 27. Asia Pacific Continuous Manufacturing in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
Figure 29. South America Continuous Manufacturing in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2018-2023
Figure 31. Middle East & Africa Continuous Manufacturing in Pharmaceutical Revenue & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 33. By Company, U.S. Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 34. By Type, U.S. Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 36. Europe Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 37. By Company, Europe Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 38. By Type, Europe Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 39. By Application, Europe Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 40. China Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 41. By Company, China Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 42. By Type, China Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 43. By Application, China Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 44. Japan Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 45. By Company, Japan Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 46. By Type, Japan Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 47. By Application, Japan Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 48. South Korea Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 49. By Company, South Korea Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 50. By Type, South Korea Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 51. By Application, South Korea Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 52. Southeast Asia Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 53. By Company, Southeast Asia Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 54. By Type, Southeast Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 55. By Application, Southeast Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 56. India Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 57. By Company, India Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 58. By Type, India Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 59. By Application, India Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 60. Middle East & Asia Continuous Manufacturing in Pharmaceutical Revenue, 2018-2029, (US$ Million)
Figure 61. By Company, Middle East & Asia Continuous Manufacturing in Pharmaceutical Market Share, 2018-2023
Figure 62. By Type, Middle East & Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 63. By Application, Middle East & Asia Continuous Manufacturing in Pharmaceutical Revenue Market Share, 2022 VS 2029
Figure 64. Research Methodology
Figure 65. Breakdown of Primary Interviews
Figure 66. Bottom-up Approaches
Figure 67. Top-down Approaches
Research Methodology:
Continuous Manufacturing in Pharmaceutical Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|